Red yeast rice contains naturally occurring monacolin K to support healthy cholesterol.

Red yeast rice contains monacolin K, which is chemically identical to the prescription statin lovastatin. It inhibits cholesterol synthesis through the same HMG-CoA reductase pathway and produces measurable LDL reductions in clinical trials.
1,200–2,400 mg/day of a standardized extract, providing 5–10 mg of monacolin K. Lower starting doses help assess tolerance. Pair with CoQ10 (100–200 mg) since the same pathway depletes CoQ10.
Yes — possible muscle aches, liver enzyme elevations, and (rarely) rhabdomyolysis. Don't combine with prescription statins. Avoid in pregnancy, liver disease, or with grapefruit juice. Monitor liver enzymes if taking long-term.
Prescription statins are dose-standardized and FDA-regulated. Red yeast rice content of monacolin K varies dramatically between products. Statins reduce LDL more (30–50%); red yeast rice reduces LDL 15–25%. RYR works for milder elevations or statin intolerance.
LDL changes appear within 4–8 weeks. Recheck a lipid panel at 8–12 weeks to assess effect. Some people respond robustly, others less so — a trial-and-recheck approach is standard.
Both prescription statins and RYR inhibit the mevalonate pathway, which also produces CoQ10. Supplementing 100–200 mg CoQ10 may reduce muscle aches and fatigue commonly reported with these compounds.
FDA has warned that products containing significant monacolin K are technically unapproved drugs. Many products on the market have been reformulated to contain little or no monacolin K — making them ineffective. Choose brands with verified content.
Yes — common stacks include RYR with bergamot, plant sterols, or psyllium. Don't combine RYR with prescription statins (additive toxicity risk) or fibrates without clinician oversight.